The virus is known as a retrovirus called XMRV.
The study is published this month in the Proceedings of the National Academy of Sciences. If further research proves that this virus leads to prostate cancer, doctors hope to create new diagnostic tests and vaccines.
Prostate cancer is the second most common cancer among men in the US and is expected to affect about 200,000 men this year.